Norwegian Crown Princess Successfully Undergoes Lung Transplant After Just 12-Day Wait, Survival Rate Nearly 90%
Key facts
- Norwegian Crown Princess Successfully Undergoes Lung Transplant After Just 12-Day Wait, Survival Rate Nearly 90%
- Norwegian Crown Princess Mette-Marit has successfully undergone a lung transplant at Oslo University Hospital, with the waiting period lasting only 12 days. The royal family confirmed the surgery went well, and the one-year survival rate for such transplants in Norway is approximately 85–90%.
- Source: PR Times
- Date: June 17, 2026
Direct answer
Norwegian Crown Princess Mette-Marit has successfully undergone a lung transplant at Oslo University Hospital, with the waiting period lasting only 12 days. The royal family confirmed the surgery went well, and the one-year survival rate for such transplants in Norway is approximately 85–90%.
- Citation
- Norwegian Crown Princess Successfully Undergoes Lung Transplant After Just 12-Day Wait, Survival Rate Nearly 90% (June 17, 2026), PR Times
- Source
- PR Times
- Date
- June 17, 2026
Norwegian Crown Princess Mette-Marit has successfully undergone a lung transplant at Oslo University Hospital, with the waiting period lasting only 12 days. The royal family confirmed the surgery went well, and the one-year survival rate for such transplants in Norway is approximately 85–90%.
📋 Article Processing Timeline
- 📰 Published: June 17, 2026 at 18:33
- 🔍 Collected: June 17, 2026 at 18:45 (12 min after Published)
- 🤖 AI Analyzed: June 19, 2026 at 06:38 (35h 52m after Collected)
Central News
(Central News Agency reporter Wu Qi-Lin, Helsinki, June 17) Norwegian Crown Princess Mette-Marit successfully underwent a lung transplant surgery today, with the royal family announcing the operation was successful. From being placed on the waiting list to receiving the transplant, the process took only 12 days.
According to a royal statement, Arnt Fiane, Head of Thoracic Surgery at Oslo University Hospital, said, "The lung transplant has proceeded successfully so far," and expressed gratitude to all team members involved in the planning and execution.
Following the surgery, the Crown Princess will remain hospitalized at Oslo University Hospital for several weeks to adjust medications, manage potential complications, and begin rehabilitation exercises. Are Holm, Head of Pulmonology, stated this is standard procedure for all new transplant patients.
Crown Prince Haakon has adjusted his schedule to stay by his wife’s side during her hospitalization. The royal family expressed gratitude to the public, saying, "We have received many warm messages of support recently, and this kindness means a great deal during this difficult time."
Dr. Holm cautioned that the recovery period after lung transplantation remains high-risk, with common postoperative complications including bleeding, infection, and kidney failure. Intensive care may last from several days to weeks. According to statistics from Oslo University Hospital, one-year survival rates for lung transplant patients in Norway are approximately 85–90%, five-year survival rates are 70–75%, and about half of patients survive beyond ten years.
Norwegian newspaper VG reported that Jesper Magnusson, Director of Lung Transplantation at Sahlgrenska University Hospital in Sweden, explained that while transplantation significantly improves quality of life for most patients, it is not a "cure." Patients must take immunosuppressive drugs for life and attend regular follow-up appointments. He noted that one of the most significant changes for many patients is finally being freed from chronic breathing difficulties: "Being able to breathe normally means even everyday tasks like climbing stairs are no longer a struggle."
The 52-year-old Mette-Marit was diagnosed with pulmonary fibrosis in 2018, a disease that gradually replaces healthy lung tissue with scar tissue, causing the lungs to stiffen and making breathing increasingly difficult. On May 17, Norway’s Constitution Day, she made her last public appearance, attending events with an oxygen supply device and needing frequent rest breaks.
Norwegian Broadcasting Corporation (NRK) reported that after news of Mette-Marit’s placement on the transplant waiting list was announced on June 5, organ donor registrations in Norway surged. The Norwegian Organ Donation Foundation (Stiftelsen Organdonasjon) reported that the following day, 2,178 people completed donor registration cards—31 times the daily average in May. (Editor: Zhang Zhixuan) 1150617
Stand with facts. Your support is a vital force in defending press freedom.
Download the Central News Agency's "First News" app to stay updated with real-time news.
Text, images, and videos on this website may not be reproduced, broadcast, publicly transmitted, or used without authorization.
(Central News Agency reporter Wu Qi-Lin, Helsinki, June 17) Norwegian Crown Princess Mette-Marit successfully underwent a lung transplant surgery today, with the royal family announcing the operation was successful. From being placed on the waiting list to receiving the transplant, the process took only 12 days.
According to a royal statement, Arnt Fiane, Head of Thoracic Surgery at Oslo University Hospital, said, "The lung transplant has proceeded successfully so far," and expressed gratitude to all team members involved in the planning and execution.
Following the surgery, the Crown Princess will remain hospitalized at Oslo University Hospital for several weeks to adjust medications, manage potential complications, and begin rehabilitation exercises. Are Holm, Head of Pulmonology, stated this is standard procedure for all new transplant patients.
Crown Prince Haakon has adjusted his schedule to stay by his wife’s side during her hospitalization. The royal family expressed gratitude to the public, saying, "We have received many warm messages of support recently, and this kindness means a great deal during this difficult time."
Dr. Holm cautioned that the recovery period after lung transplantation remains high-risk, with common postoperative complications including bleeding, infection, and kidney failure. Intensive care may last from several days to weeks. According to statistics from Oslo University Hospital, one-year survival rates for lung transplant patients in Norway are approximately 85–90%, five-year survival rates are 70–75%, and about half of patients survive beyond ten years.
Norwegian newspaper VG reported that Jesper Magnusson, Director of Lung Transplantation at Sahlgrenska University Hospital in Sweden, explained that while transplantation significantly improves quality of life for most patients, it is not a "cure." Patients must take immunosuppressive drugs for life and attend regular follow-up appointments. He noted that one of the most significant changes for many patients is finally being freed from chronic breathing difficulties: "Being able to breathe normally means even everyday tasks like climbing stairs are no longer a struggle."
The 52-year-old Mette-Marit was diagnosed with pulmonary fibrosis in 2018, a disease that gradually replaces healthy lung tissue with scar tissue, causing the lungs to stiffen and making breathing increasingly difficult. On May 17, Norway’s Constitution Day, she made her last public appearance, attending events with an oxygen supply device and needing frequent rest breaks.
Norwegian Broadcasting Corporation (NRK) reported that after news of Mette-Marit’s placement on the transplant waiting list was announced on June 5, organ donor registrations in Norway surged. The Norwegian Organ Donation Foundation (Stiftelsen Organdonasjon) reported that the following day, 2,178 people completed donor registration cards—31 times the daily average in May. (Editor: Zhang Zhixuan) 1150617
Stand with facts. Your support is a vital force in defending press freedom.
Download the Central News Agency's "First News" app to stay updated with real-time news.
Text, images, and videos on this website may not be reproduced, broadcast, publicly transmitted, or used without authorization.
FAQ
When was the Norwegian Crown Princess's lung transplant performed?
The surgery took place on June 17, 2025, at Oslo University Hospital.
What is the survival rate after lung transplantation?
In Norway, one-year survival is 85–90%, five-year is 70–75%, and about 50% survive past ten years.
What illness does the Crown Princess have?
She was diagnosed with pulmonary fibrosis in 2018, a progressive lung disease causing stiffness and breathing difficulty.
How long is the typical transplant waiting period?
In Norway, it's shorter than average; Princess Mette-Marit received her transplant in just 12 days.
Do patients need medication after lung transplant?
Yes, lifelong immunosuppressive drugs and regular check-ups are required.